Search clinical trials for: Immunotherapy toxicity
Total 5541 results
-
Central Hospital, Nancy, FranceUniversity Hospital, Strasbourg, France; CHU de Reims; European Georges Pompidou... and other collaboratorsRecruitingChemotherapeutic ToxicityFrance
-
National Cancer Institute (NCI)Not yet recruitingB Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage
-
Sun Yat-sen UniversityRecruitingEfficacy | Toxicity | Esophageal Squamous Cell CarcinomaChina
-
Haoming (Carl) QiuNot yet recruiting
-
Sun Yat-sen UniversityFirst People's Hospital of Foshan; The First Affiliated Hospital, Guangzhou... and other collaboratorsRecruitingHepatocellular Carcinoma | Chemotherapy Effect | Chemotherapeutic ToxicityChina
-
Michael von WolffUniversity of BernNot yet recruitingCancer | Fertility Issues | Effects of Immunotherapy | Toxicity Due to Chemotherapy | Toxicity Due to Radiotherapy | Fertility Preservation
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingMelanoma | Kidney Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Bladder Cancer | Skin Cancer | Head Neck CancerItaly
-
Universitair Ziekenhuis BrusselRecruitingDietary Habits | Immune-related Adverse EventBelgium
-
Erasmus Medical CenterRecruitingImmunotherapy | Melanoma Stage IV | Melanoma Stage III | Toxicity, DrugNetherlands
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
AstraZenecaParexelRecruitingRelapsed or Refractory Classical Hodgkin LymphomaItaly, United States, Spain, United Kingdom, Canada, Denmark, France, China, Germany
-
Sheba Medical CenterRambam Health Care Campus; AstraZeneca; Tel-Aviv Sourasky Medical CenterRecruitingMetastatic or Locally Advanced NSCLCIsrael
-
M.D. Anderson Cancer CenterRecruitingClinical Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIB Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 | Pathologic Stage IIID Cutaneous Melanoma AJCC v8 | Pathologic Stage III Cutaneous Melanoma AJCC v8 | Pathologic Stage IIIA Cutaneous Melanoma... and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Lung Non-Squamous Non-Small Cell Carcinoma | Stage IIIB Lung Cancer AJCC v8United States
-
Jessa HospitalHasselt UniversityRecruitingImmunotoxicity | Skin ToxicityBelgium
-
NovoCure GmbHMerck Sharp & Dohme LLCRecruiting
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenRecruitingImmunotherapy | Pneumonitis, Interstitial | Immune-related Adverse EventsBelgium
-
Universitaire Ziekenhuizen KU LeuvenKU LeuvenRecruitingNSCLC | Lung Diseases, Interstitial | ImmunotherapyBelgium
-
Azienda Ospedaliero-Universitaria CareggiRecruitingBrain Metastases From NSCLCItaly
-
Leiden University Medical CenterJessa Hospital; The Netherlands Cancer InstituteRecruitingImmunotherapy | Non Small Cell Lung Cancer Stage IIINetherlands, Belgium
-
Western Sydney Local Health DistrictBristol-Myers Squibb; University of Western SydneyRecruitingMelanoma | Renal Cell Carcinoma | Hepatocellular Carcinoma | Gastric Cancer | Mesothelioma | Endometrial Cancer | Lung Cancer, Nonsmall CellAustralia
-
Icahn School of Medicine at Mount SinaiRecruitingCancer | Thyroid | PD-1United States
-
Sunnybrook Health Sciences CentreUniversity of Toronto; Princess Margaret Hospital, CanadaRecruiting
-
Massachusetts General HospitalDana-Farber Cancer InstituteRecruitingMelanoma Stage IV | Melanoma Stage III | Drug Toxicity | Immune-related Adverse Event | Skin Cancer Stage III | Skin Cancer Stage IV | Drug-Induced ColitisUnited States
-
CCTU- Cancer ThemeMicrobiotica LtdRecruitingMelanoma | Lung Cancer | Renal CancerUnited Kingdom
-
Institut Claudius RegaudRecruiting
-
Lawson Health Research InstituteAcademic Medical Organization of Southwestern OntarioActive, not recruiting
-
Leiden UniversityBristol-Myers SquibbActive, not recruitingEffects of Immunotherapy | Adverse Drug Event | Toxicity, DrugNetherlands
-
Institut Claudius RegaudCompleted
-
Hospices Civils de LyonCompletedAdverse Effect | Renal ToxicityFrance
-
National Cancer Institute (NCI)TerminatedKidney Cancer | Renal CancerUnited States
-
National Cancer Institute (NCI)CompletedMelanoma | Neoplasm MetastasisUnited States
-
Shanghai Chest HospitalNot yet recruitingEsophageal CancerChina
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingPrecursor Cell Lymphoblastic Leukemia-Lymphoma
-
Assiut UniversityNot yet recruitingLiver Toxicity, Chemically-Induced
-
Washington University School of MedicineAmerican Academy of Clinical ToxicologyNot yet recruiting
-
Institut du Cancer de Montpellier - Val d'AurelleNot yet recruiting
-
RenJi HospitalRecruitingImmunotherapy | Locally Advanced Cervical Carcinoma | Concurrent ChemoradiotherapyChina
-
H. Lee Moffitt Cancer Center and Research InstituteAngiodynamics, Inc.RecruitingPancreatic Cancer | Locally Advanced Pancreatic CancerUnited States
-
Rigshospitalet, DenmarkNot yet recruitingHematologic Cancer | CRS - Cytokine Release Syndrome
-
Francesco De CobelliA.O. Ospedale Papa Giovanni XXIII; Cardarelli Hospital; AOU Pisana, Pisa, ItalyNot yet recruitingIntrahepatic CholangiocarcinomaItaly
-
Yehua ShenNot yet recruitingHCC - Hepatocellular Carcinoma
-
Saint Petersburg State University, RussiaRecruitingAnaplastic Thyroid CancerRussian Federation
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingParaneoplastic Sensory NeuronopathyFrance
-
Cancer Institute and Hospital, Chinese Academy...RecruitingGastric Cancer | Diffuse Type CarcinomaChina
-
Hebei Medical University Fourth HospitalRecruitingSCLC, Limited StageChina
-
Fudan UniversityNot yet recruiting
-
PhotonPharma, Inc.Not yet recruiting
-
Beijing 302 HospitalBeijing GD Initiative Cell Therapy Technology Co., Ltd.; Chinese Academy of...Not yet recruiting
-
ImmunoGen, Inc.Not yet recruitingRecurrent Ovarian Cancer | Folate Receptor-Alpha PositiveUnited States, Spain, Australia, Belgium, Canada, France, Ireland, Italy